A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women

Abstract

The dapivirine vaginal ring has a safety and pharmacokinetic profile that supports its use as a sustained-release topical microbicide for HIV-1 prevention in women.